💨 Abstract

Remlife Global PTE LTD., a subsidiary of India's Remedium Lifecare Ltd., has partnered with JiyaYu Lifesciences to replace animal-origin raw materials in pharmaceutical manufacturing. This collaboration, focused on developing fermentation and biocatalyst-based alternatives, will see Remlife Global commercialize these technologies in multiple countries. With potential annual revenues hitting INR 100 crore and growing, the initiative aims to enhance sustainability, ethical standards, and supply chain resilience.

Courtesy: theprint.in

Summarized by Einstein Beta 🤖